Glesatinib, a c-MET/SMO Dual Inhibitor, Antagonizes P-glycoprotein Mediated Multidrug Resistance in Cancer CellsQingbin Cui, Zhe‐Sheng Chen, Chao‐Yun Cai et al.|Frontiers in Oncology|2019Cited by 42
ABCG2 Overexpression Contributes to Pevonedistat ResistanceRishil J. Kathawala, Steffan T. Nawrocki, Zhe‐Sheng Chen et al.|Cancers|2020Cited by 16
MG53 inhibits cellular proliferation and tumor progression in colorectal carcinomaPranav Gupta, Zhe‐Sheng Chen|International Journal of Biological Sciences|2022Cited by 10
Pharmacokinetics of an oral VEGF receptor tyrosine kinase inhibitor (PTK787/ZK222584) in patients with myelodysplastic syndrome (MDS): Cancer and Leukemia Group B Study 10105Pranav Gupta, Mark J. Ratain, Richard A. Larson et al.|Journal of Clinical Oncology|2006Cited by 3